Headquartered in Erkrath, Germany, sangro has been a key distributor in the German homecare market for the past three decades. With approximately 340 employees, sangro links more than 200 manufacturers to over 3,000 medical supply stores and homecare providers nationwide. Each year, the company supplies a broad range of products across wound, ostomy and incontinence care, nutrition and medical aids, delivering to more than 1 million patients’ homes.
Sangro will be carved out of GHD GesundHeits GmbH, owned by Nordic Capital, and will operate as an independent company upon completion of the transaction, which is expected in the first half of 2026.
“Sangro is a leading distributor and logistics provider in the German homecare market, with nationwide coverage and long-standing supplier and customer relationships,” says Jan-Nicolas Garbe, Partner at Axcel. “Together with management, our aim is to develop sangro into a strong standalone company and further build its footprint across Germany. We look forward to putting Axcel’s experience in carve-outs to work, building a solid foundation for long-term growth in a sector we know well.”
Rising demand for homecare
Sangro operates in a resilient and growing market with rising demand for homecare products and services, driven by an ageing population, an increasing prevalence of chronic disease and a shift towards outpatient and at-home care.
“As a leading distributor and logistics provider in this market, sangro plays an essential role in ensuring fast, reliable and high-quality supply of homecare products to patients across Germany,” says Michael Tripp, CEO of sangro. “With Axcel’s backing, we gain an experienced partner for the next chapter as an independent company, enabling us to further expand, win new customers and strengthen the important services we provide.”
In addition to distribution, sangro provides value-added services, including product selection guidance, inventory management and documentation handling.
The partnership with sangro marks Axcel VII’s 11th investment.